Advice
The first goal is to provide advice on the target-oriented development of drugs from start-up companies or SMEs in the areas of health care, diagnostics and therapy. This also includes independent reports on project developments commissioned by board members or investors. The consulting expertise is based on decades of experience in the research and development of different drugs and therapeutic approaches.

Evaluation
The second goal is the planning, tracking and evaluation of in vitro experiments and preclinical and clinical studies in the field of pharmacokinetics and pharmacodynamics, the writing of reports and the creation of “Investigator Brochures” as well as the corresponding chapters of the approval documents (EU, FDA)

Products
The third goal is the investor-supported further development of the strongest plant estrogen (8-prenylnaringenin from hop cones) as a topical preparation for aging skin (“anti-wrinkle cream”), for vaginal use and for a novel oral use as hormone replacement therapy (HRT ) without and with added progestin. Furthermore, oral applications in the area of arteriosclerosis prophylaxis (alone or in combination with inhibition of platelet aggregation) are of considerable medical interest, especially for older men. You can find a summary of the projects HERE.